Olmesartan medoxomil: current status of its use in monotherapy
Hans R BrunnerLausanne University, Lausanne and Medizinische Poliklik, Universitaetsspital, Basel, SwitzerlandAbstract: Olmesartan medoxomil is an angiotensin II receptor antagonist. In pooled analyses of seven randomized, double-blind trials, 8 weeks’ treatment with olmesartan medoxomil w...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2006-12-01
|
| Series: | Vascular Health and Risk Management |
| Online Access: | https://www.dovepress.com/olmesartan-medoxomil-current-status-of-its-use-in-monotherapy-peer-reviewed-article-VHRM |